Research
Stem cell–derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice
Phys.org ·
The Brief
- In type 1 diabetes, the immune system attacks insulin-producing cells in the pancreas.
- Insulin therapy helps manage the disease but does not stop the underlying immune attack.
- Stem cell-derived nanoparticles were reported to modulate immune cells and help delay type 1 diabetes in mice.
Why it matters
The work targets the immune attack behind type 1 diabetes rather than only blood sugar management, but the sources report results in mice only, so relevance to people is not yet established.
Who’s affected
- researchers in diabetes and immunology
- people living with type 1 diabetes
In people with type 1 diabetes, the immune system mistakenly identifies insulin-producing cells in the pancreas as foreign and attacks them, leaving the body unable to properly regulate blood sugar. While insulin therapy helps manage the disease, it does not stop the underlying…